• Ocugen at Piper Sandler ophthalmology day: gene therapy push advances Investing.com Fri, 10 Jul 2026 14:45:48 GMT
• Ocugen’s Triple-Threat Pipeline: A $130M Cash Injection and a Summer of Make-or-Break Data AD HOC NEWS Thu, 09 Jul 2026 02:31:32 GMT
• ocgn stock rallies on wall street optimism for clinical pipeline: retail awaits new data Stocktwits Tue, 07 Jul 2026 18:54:42 GMT
• ocgn stock rallies on wall street optimism for clinical pipeline: retail awaits new data Stocktwits Sun, 05 Jul 2026 07:06:56 GMT
• ocugen enters a high-stakes summer: conference season meets make-or-break trial results Ad-hoc-news.de Sat, 04 Jul 2026 03:04:39 GMT
• ocgn stock rallies on wall street optimism for clinical pipeline: retail awaits new data Stocktwits Fri, 03 Jul 2026 11:59:05 GMT
• ocugen's two-pronged catalyst calendar heats up as ocu410 data and ocu400 filing converge AD HOC NEWS Thu, 02 Jul 2026 10:11:23 GMT
• ocugen lands $115m convertible note as gene therapy pipeline enters three-pronged catalyst phase AD HOC NEWS Wed, 01 Jul 2026 16:16:20 GMT
• ocugen to present gene therapy advances at july 2026 industry conferences Pluang Wed, 01 Jul 2026 11:10:37 GMT
• Ocugen to Participate in Upcoming July Industry Conferences Yahoo Finance Wed, 01 Jul 2026 11:00:00 GMT
• Ocugen’s July retina conference talks include OCU410 phase 2 results Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• ocgn stock rallies on wall street optimism for clinical pipeline: retail awaits new data Stocktwits Tue, 30 Jun 2026 11:01:38 GMT
• ocugen rides index inclusion rally while gene therapy trials enter defining phase AD HOC NEWS Tue, 30 Jun 2026 03:32:56 GMT
• Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 21:08:02 GMT
• ocugen, inc.(nasdaqcm: ocgn) added to russell 2500 growth benchmark marketscreener.com Mon, 29 Jun 2026 19:41:25 GMT
• ocugen’s cfo makes a rare open-market buy as institutional investors pile in ahead of key gene the Ad-hoc-news.de Mon, 29 Jun 2026 15:45:40 GMT
• Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Value Benchmark marketscreener.com Mon, 29 Jun 2026 15:21:59 GMT
• ocugen, inc.(nasdaqcm: ocgn) added to russell 3000e index marketscreener.com Mon, 29 Jun 2026 06:43:22 GMT
• ocugen, inc.(nasdaqcm: ocgn) added to russell microcap index marketscreener.com Mon, 29 Jun 2026 05:33:46 GMT
• ocugen, inc.(nasdaqcm: ocgn) added to russell 2500 value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ocugen, inc.(nasdaqcm: ocgn) added to russell 3000 growth benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ocugen, inc.(nasdaqcm: ocgn) added to russell small cap comp value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ocugen, inc.(nasdaqcm: ocgn) added to russell 2000 dynamic index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ocgn stock holds buy rating as analyst sees key catalysts ahead StocksToTrade Fri, 26 Jun 2026 18:02:00 GMT
• enterprise value to ebitda forward of ocugen, inc. – nasdaq:ocgn TradingView Fri, 26 Jun 2026 13:39:16 GMT
• has ocugen's recent convertible notes offering stabilized its financial future Kavout | AI Fri, 26 Jun 2026 13:29:29 GMT
• enterprise value to revenue forward of ocugen, inc. – nasdaq:ocgn TradingView Fri, 26 Jun 2026 01:59:09 GMT
• ocugen's gene-agnostic eye therapies could reshape late-stage care MSN Fri, 26 Jun 2026 01:10:58 GMT
• enterprise value to ebit forward of ocugen inc – swb:2h51 TradingView Thu, 25 Jun 2026 20:34:24 GMT
• Ocugen: Financing Risk Is Lower, But The Clinical Bet Still Has To Work Seeking Alpha Thu, 25 Jun 2026 04:35:54 GMT
• ocugen (ocgn) stock draws fresh price target split after cautious analyst view Yahoo Finance Thu, 25 Jun 2026 00:23:00 GMT
• ocgn stock rallies on wall street optimism for clinical pipeline: retail awaits new data Stocktwits Wed, 24 Jun 2026 18:04:13 GMT
• ocugen inc (ocgn) financial health: profitability & balance sheet analysis TradingKey Wed, 24 Jun 2026 07:14:53 GMT
• Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• ocgn stock holds buy rating as analyst trims price target StocksToTrade Tue, 23 Jun 2026 18:03:00 GMT
• ocugen's gene-agnostic eye therapies could reshape late-stage care MSN Tue, 23 Jun 2026 02:52:33 GMT
• ocugen cfo puts own capital to work as gene therapy pipeline delivers early efficacy signal AD HOC NEWS Sat, 20 Jun 2026 17:16:34 GMT
• ocugen’s cfo bets on her own stock while a $130m cash hoard fuels three drug approvals AD HOC NEWS Sat, 20 Jun 2026 13:47:16 GMT
• ocugen's three-bla ambition: one filing starts this quarter as the market waits for proof AD HOC NEWS Sat, 20 Jun 2026 04:05:13 GMT
• ocugen's gene-agnostic eye therapies could reshape late-stage care MSN Fri, 19 Jun 2026 10:44:20 GMT
• ocugen cfo buys into the dip as $130m convertible note funds a trio of clinical catalysts AD HOC NEWS Thu, 18 Jun 2026 16:14:28 GMT
• ocugen inc (ocgn) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 14:55:55 GMT
• Ocugen (NASDAQ: OCGN) CFO purchases 21,000 shares in open-market trade Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• ocugen inc (ocgn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 06:18:58 GMT
• ocugen nears binary moment as phase 3 enrollment closes and stock sinks 55% from peak AD HOC NEWS Tue, 16 Jun 2026 14:23:12 GMT
• ocugen’s shares leap 32% post oppenheimer’s positive coverage timothysykes.com Mon, 15 Jun 2026 20:14:00 GMT
• Director at Ocugen (NASDAQ: OCGN) awarded 170,100 stock options Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• ocugen (nasdaq: ocgn) director awarded 170,100 stock options at $1.22 strike Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• ocugen (nasdaq: ocgn) director receives grant of 170,100 stock options at $1.22 Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• ocugen (ocgn) director uday kompella awarded 170,100 stock options at $1.22 strike Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• ocugen's cash runway through 2028 and new cmo set stage for pivotal q3 data AD HOC NEWS Sat, 13 Jun 2026 16:13:15 GMT
• ocugen shareholders greenlight board and audit terms as pipeline data looms over stagnant stock AD HOC NEWS Sat, 13 Jun 2026 14:24:34 GMT
• ocugen confirms chief medical officer and extends cash runway as market awaits pivotal gene therapy AD HOC NEWS Sat, 13 Jun 2026 01:04:50 GMT
• ocugen's pipeline nears binary catalysts as 800% analyst upside collides with market skepticism AD HOC NEWS Fri, 12 Jun 2026 15:26:33 GMT
• ocgn: all agenda items, including director elections and compensation votes, were approved TradingView Thu, 11 Jun 2026 13:06:46 GMT
• Ocugen (NASDAQ: OCGN) shareholders back pay, elect directors and confirm new CMO Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• ocugen faces a defining week: shareholder vote and a $130m bet on three gene therapy approvals AD HOC NEWS Thu, 11 Jun 2026 03:24:08 GMT
• ocugen's gene-agnostic eye therapies could reshape late-stage care MSN Wed, 10 Jun 2026 11:36:12 GMT
• for ocugen, a divergence between fda tailwinds and market reality AD HOC NEWS Wed, 10 Jun 2026 04:13:00 GMT
• ocgn stock rallies on wall street optimism for clinical pipeline: retail awaits new data Stocktwits Mon, 08 Jun 2026 16:14:45 GMT
• ocugen's gene-agnostic eye therapies could reshape late-stage care MSN Sun, 07 Jun 2026 19:30:00 GMT
• ocugen's gene-agnostic eye therapies could reshape late-stage care MSN Sat, 06 Jun 2026 16:12:14 GMT
• how the ocugen (ocgn) investment story is evolving without new analyst guidance Yahoo Finance Sat, 06 Jun 2026 01:05:00 GMT
• ocgn stock rallies on wall street optimism for clinical pipeline: retail awaits new data Stocktwits Fri, 05 Jun 2026 09:26:07 GMT
• How The Ocugen (OCGN) Investment Story Is Evolving Without New Analyst Guidance Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• ocugen's gene-agnostic eye therapies could reshape late-stage care MSN Fri, 05 Jun 2026 02:01:01 GMT
• Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report? Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• ocugen (ocgn) noble capital markets june 2026 emerging growth virtual equity conference summary Quartr Thu, 04 Jun 2026 07:00:00 GMT
• ocugen consolidates financial leadership under new accounting officer The Globe and Mail Thu, 04 Jun 2026 07:00:00 GMT
• is ocgn stock worth the risk ahead of 2026-27 eye gene therapy data? TradingView Wed, 03 Jun 2026 15:39:00 GMT
• Ocugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Care Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• ocgn's catalyst calendar for trial data and filings through 2028 Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• ocugen (nasdaq: ocgn) cfo assumes principal accounting role Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• ocugen inc stock (us67577c1053): conference schedule and pre-market moves in focus AD HOC NEWS Tue, 02 Jun 2026 16:30:01 GMT
• Ocugen to Participate in Upcoming June Investor and Industry Conferences GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• Eye gene therapy for blindness hits stage at three June events Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• ocugen, assertio among healthcare stocks set to join russell microcap; definium therapeutics, tvardi therapeutics to exit MSN Mon, 01 Jun 2026 19:15:19 GMT
• ocugen’s modifier platform delivers 31% lesion reduction as pipeline nears fda filings and russell AD HOC NEWS Wed, 27 May 2026 22:20:43 GMT
• ocugen price target cut to $11.00/share from $12.00 by canaccord genuity Moomoo Wed, 27 May 2026 20:26:33 GMT
• three speculative biotech penny stocks with pipeline catalysts Kalkine Media Wed, 27 May 2026 18:44:00 GMT
• ocgn maintained by canaccord genuity -- price target lowered to $11 GuruFocus Wed, 27 May 2026 13:50:37 GMT
• ccorf maintains ocugen(ocgn.us) with buy rating, cuts target price to $11 Moomoo Wed, 27 May 2026 11:39:35 GMT
• canaccord lowers ocugen stock price target to $11 on model update Investing.com Wed, 27 May 2026 07:00:00 GMT
• ocugen's pipeline countdown accelerates alongside russell microcap admission AD HOC NEWS Wed, 27 May 2026 02:31:41 GMT
• russell 3000 shuffle: ocugen, nektar slated to join among healthcare stocks; nano-x to drop off MSN Tue, 26 May 2026 17:55:52 GMT
• ocugen, assertio among healthcare stocks set to join russell microcap; definium therapeutics, tvardi therapeutics to exit MSN Tue, 26 May 2026 12:11:33 GMT
• ocugen (ocgn) set for inclusion in russell 3000 index rebalancin GuruFocus Tue, 26 May 2026 12:11:15 GMT
• ftse russell index reconstitution sees major changes with ocugen (ocgn) joining GuruFocus Tue, 26 May 2026 09:14:47 GMT
• ocugen extends cash runway to 2028 with $130m convertible, but cmo vacancy and stock slide test inve AD HOC NEWS Sat, 23 May 2026 11:33:42 GMT
• ocugen's stock tests critical floor as analysts hold firm on $9.75 target ahead of stifel forum pitc AD HOC NEWS Fri, 22 May 2026 12:34:49 GMT
• ocugen inc stock (us67577c1053): fda feedback keeps retinitis pigmentosa trial on track AD HOC NEWS Thu, 21 May 2026 17:36:40 GMT
• ocugen sets ambitious three-bla goal by 2027 after $130m convertible bolsters balance sheet AD HOC NEWS Tue, 19 May 2026 04:22:22 GMT
• ocugen replaces top medical officer as cash runway extends to 2028 — but stock stays stuck in over AD HOC NEWS Sun, 17 May 2026 02:41:21 GMT
• ocugen cuts borrowing costs by nearly half after $130m convertible, as ocu410 data shows 31% lesion AD HOC NEWS Sat, 16 May 2026 15:24:20 GMT
• ocugen’s $130m convertible and new medical chief signal urgency as ocu400 bla approaches AD HOC NEWS Fri, 15 May 2026 15:53:07 GMT
• gene therapy pipeline accelerates as ocugen, inc. targets approvals for rp and stargardt disease Traders Union Fri, 15 May 2026 02:29:10 GMT
• Has Ocugen's Recent Convertible Notes Offering Stabilized Its Financial Future Kavout | AI Fri, 15 May 2026 01:50:49 GMT
• ocugen raises $130 million through convertible notes offering TipRanks Thu, 14 May 2026 23:24:45 GMT
• ocugen announces interim chief medical officer appointment transition TipRanks Thu, 14 May 2026 23:24:44 GMT
• has ocugen's recent convertible notes offering stabilized its financial future Kavout Thu, 14 May 2026 21:30:23 GMT
Ocugen, Inc(NASDAQ:OCGN) 
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherit...
Website: http://www.ocugen.com
Founded: 2013
Full Time Employees: 16
CEO / Co-Founder: Shankar Musunuri
Sector: Healthcare
Industry: Biotechnology